Aidoo A, Lyn-Cook L E, Heflich R H, George E O, Casciano D A
Department of Health and Human Services, Food and Drug Administration, Jefferson, AR.
Mutat Res. 1993 Jan;298(3):169-78. doi: 10.1016/0165-1218(93)90038-f.
The persistence of 6-thioguanine-resistant (TGr) T-lymphocytes was investigated in Fischer 344 rats treated with N-ethyl-N-nitrosourea (ENU) using two schedules. Male rats, aged 3 months, were given i.p. injections containing a total of 0, 50 or 100 mg ENU/kg either as a single treatment (single-dose group) or divided among 10 weekly treatments (split-dose group). At 1, 3, 5, 10, 20, 30 and 50 weeks after the single-dose treatment, and 10, 20, 30 and 50 weeks after beginning the split-dose regimen, animals were assayed for the frequency of TGr spleen lymphocytes. ENU produced significant dose- and time-dependent responses in the single- and the split-dose treatment groups. Although a few of the 50 mg/kg split-dose treatments were significantly higher than the comparative single-dose groups, the number of TGr lymphocytes produced by the two dosing regimens were generally similar. The frequency of TGr cells for control animals increased with the age of the animals. The mode of ENU administration did not greatly influence the percent cloning efficiency (%CE) of the non-selection cultures, although the %CE declined in animals over 10 months of age. To investigate the relationship between the frequency of TGr cells and the age of the animals at the time of ENU administration, additional rats aged 17 months were treated with a single dose of ENU and at 1, 5 and 10 weeks following exposure, the frequencies of TGr cells were determined from the isolated lymphocytes. No difference in mutagen sensitivity between rats treated at 3 months of age and those treated at 17 months of age was detected at the time points evaluated. The data demonstrate the persistence of ENU-induced TGr T-lymphocytes in the rat and suggest that the dose and possibly the treatment schedule, but not the age of the animal at the time of treatment, affect the response.
采用两种给药方案,研究了用N-乙基-N-亚硝基脲(ENU)处理的Fischer 344大鼠中6-硫鸟嘌呤抗性(TGr)T淋巴细胞的持续性。3月龄雄性大鼠腹腔注射含总量为0、50或100 mg ENU/kg的溶液,要么单次给药(单剂量组),要么分10次每周给药(分次给药组)。单剂量处理后1、3、5、10、20、30和50周,以及开始分次给药方案后10、20、30和50周,检测动物脾脏TGr淋巴细胞的频率。ENU在单剂量和分次给药治疗组中产生了显著的剂量和时间依赖性反应。虽然50 mg/kg分次给药组中的一些结果显著高于相应的单剂量组,但两种给药方案产生的TGr淋巴细胞数量总体相似。对照动物的TGr细胞频率随动物年龄增加而升高。ENU的给药方式对非选择培养物的克隆效率百分比(%CE)影响不大,尽管10个月以上动物的%CE有所下降。为了研究ENU给药时TGr细胞频率与动物年龄之间的关系,对另外17月龄的大鼠单次给予ENU,并在暴露后1、5和10周,从分离的淋巴细胞中测定TGr细胞的频率。在评估的时间点,未检测到3月龄大鼠和17月龄大鼠之间诱变敏感性的差异。数据表明ENU诱导的TGr T淋巴细胞在大鼠体内持续存在,并表明剂量以及可能的给药方案,但不是给药时动物的年龄,会影响反应。